Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance

Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance

Abstract Multidrug‐resistant Acinetobacter baumannii is a top‐priority pathogen globally and polymyxins are a last‐line therapy. Polymyxin dependence in A. baumannii (i.e., nonculturable on agar without polymyxins) is a unique and highly‐resistant phenotype with a significant potential to cause trea...

Full description

Bibliographic Details
Main Authors:	Yan Zhu, Jing Lu, Mei‐Ling Han, Xukai Jiang, Mohammad A. K. Azad, Nitin A. Patil, Yu‐Wei Lin, Jinxin Zhao, Yang Hu, Heidi H. Yu, Ke Chen, John D. Boyce, Rhys A. Dunstan, Trevor Lithgow, Christopher K. Barlow, Weifeng Li, Elena K. Schneider‐Futschik, Jiping Wang, Bin Gong, Bjorn Sommer, Darren J. Creek, Jing Fu, Lushan Wang, Falk Schreiber, Tony Velkov, Jian Li
Format:	Article
Language:	English
Published:	Wiley 2020-08-01
Series:	Advanced Science
Subjects:	Acinetobacter baumannii membrane lipidomics molecular dynamics polymyxin polymyxin‐dependent resistance
Online Access:	https://doi.org/10.1002/advs.202000704

Similar Items

Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
by: Thien B. Tran, et al.
Published: (2018-04-01)

Review of the international consensus guidelines for the optimal use of the polymyxins
by: Eliseeva E.V., et al.
Published: (2019-12-01)

Progress in the study of polymyxin resistance and its mechanism
by: CAI Jia’an, et al.
Published: (2022-03-01)

Transcriptomic Responses to Polymyxin B and Analogues in Human Kidney Tubular Cells
by: Mengyao Li, et al.
Published: (2023-02-01)

The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation
by: Dongna Zou, et al.
Published: (2021-04-01)

Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens
by: Thien B. Tran, et al.
Published: (2018-04-01)

Challenges in the Detection of Polymyxin Resistance: From Today to the Future
by: Rebeca Siqueira Rubens, et al.
Published: (2024-01-01)

Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study
by: Yiying Cai, et al.
Published: (2020-07-01)

Coarse-grained simulations uncover Gram-negative bacterial defense against polymyxins by the outer membrane
by: Xukai Jiang, et al.
Published: (2021-01-01)

Metabolic Responses to Polymyxin Treatment in <italic toggle="yes">Acinetobacter baumannii</italic> ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling
by: Yan Zhu, et al.
Published: (2019-02-01)

Polymyxin B sulphate
by: 982 SIRIM

Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
by: Vasoo, Shawn
Published: (2018)

Detection of polymyxins resistance among Enterobacterales: evaluation of available methods and proposal of a new rapid and feasible methodology
by: Gabriela da Silva Collar, et al.
Published: (2023-08-01)

Design and Evaluation of Novel Polymyxin Fluorescent Probes
by: Bo Yun, et al.
Published: (2017-11-01)

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study
by: Zhenping Wu, et al.
Published: (2023-08-01)

Transcriptomic Analysis of the Activity of a Novel Polymyxin against <named-content content-type="genus-species">Staphylococcus aureus</named-content>
by: Jinxin Zhao, et al.
Published: (2016-08-01)

Molecular mechanisms of polymyxin resistance and detection of mcr genes
by: Patrik Mlynarcik, et al.
Published: (2019-02-01)

Corrigendum: Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics
by: Martti Vaara, et al.
Published: (2019-10-01)

Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii
by: Shixing Zhu, et al.
Published: (2023-06-01)

Polymyxins: To Combine or Not to Combine?
by: Federico Perez, et al.
Published: (2019-04-01)

Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
by: Cheng Lyu, et al.
Published: (2020-04-01)

Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant Pseudomonas aeruginosa
by: Yu-Wei Lin, et al.
Published: (2019-10-01)

Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii
by: Shixing Zhu, et al.
Published: (2022-09-01)

Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter baumannii
by: Mei-Ling Han, et al.
Published: (2019-07-01)

Emergence of polymyxin B-resistant Acinetobacter baumannii in hospitals in Rio de Janeiro
by: Gabrielle L. Genteluci, et al.

Lipid A Modification and Metabolic Adaptation in Polymyxin-Resistant, New Delhi Metallo-β-Lactamase–Producing Klebsiella pneumoniae
by: Jing Lu, et al.
Published: (2023-08-01)

Untargeted metabolomics to evaluate polymyxin B toxicodynamics following direct intracerebroventricular administration into the rat brain
by: Maytham Hussein, et al.
Published: (2022-01-01)

Overview of polymyxin resistance in Enterobacteriaceae
by: Kesia Esther da Silva, et al.
Published: (2022-02-01)

Polymyxin Induces Significant Transcriptomic Perturbations of Cellular Signalling Networks in Human Lung Epithelial Cells
by: Mengyao Li, et al.
Published: (2022-02-01)

Non-clonal occurrence of pmrB mutations associated with polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae in Brazil
by: Ana Claudia Souza Rodrigues, et al.
Published: (2019-05-01)

LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment
by: Huiwen Liu, et al.
Published: (2023-09-01)

Structure-Function Studies of Polymyxin B Lipononapeptides
by: Alejandra Gallardo-Godoy, et al.
Published: (2019-02-01)

Antimicrobial Peptides for Gram-Negative Sepsis: A Case for the Polymyxins
by: Sunil eDavid
Published: (2012-08-01)

Mechanistic and biophysical characterization of polymyxin resistance response regulator PmrA in Acinetobacter baumannii
by: Zhenlin Ouyang, et al.
Published: (2024-02-01)

Proteomic Response Revealed Signaling Pathways Involving in the Mechanism of Polymyxin B-Induced Melanogenesis
by: Chuhan Zhang, et al.
Published: (2022-04-01)

Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: A systematic review and meta-analysis
by: Difan Lu, et al.
Published: (2023-05-01)

Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations
by: Augustine Koh Jing Jie, et al.
Published: (2022-11-01)

Polymyxins–Curcumin Combination Antimicrobial Therapy: Safety Implications and Efficacy for Infection Treatment
by: Chongshan Dai, et al.
Published: (2020-06-01)

Comparative metabolomics revealed key pathways associated with the synergistic killing of multidrug-resistant Klebsiella pneumoniae by a bacteriophage-polymyxin combination
by: Mei-Ling Han, et al.
Published: (2022-01-01)

Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Polymyxin-Based Combinations
by: Marisol Wences, et al.
Published: (2022-07-01)